These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 2657284

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Drug therapy of peptic ulcer disease.
    Ching CK, Lam SK.
    Br J Hosp Med; ; 54(2-3):101-6. PubMed ID: 7551483
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The limitations of current therapy in peptic ulcer disease.
    Salena BJ, Hunt RH.
    Clin Invest Med; 1987 May; 10(3):171-7. PubMed ID: 3304747
    [Abstract] [Full Text] [Related]

  • 33. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I, Herszényi L, Juhász M, Miheller P, Tulassay Z.
    Orv Hetil; 2006 Mar 12; 147(10):435-9. PubMed ID: 16573172
    [Abstract] [Full Text] [Related]

  • 34. Long-term treatment of duodenal ulcer.
    Wormsley KG.
    Postgrad Med J; 1988 Mar 12; 64 Suppl 1():47-53. PubMed ID: 3047725
    [Abstract] [Full Text] [Related]

  • 35. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H.
    Hepatogastroenterology; 2004 Mar 12; 51(56):338-42. PubMed ID: 15086153
    [Abstract] [Full Text] [Related]

  • 36. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
    Gostishchev VK, Evseev MA.
    Khirurgiia (Mosk); 2005 Mar 12; (8):52-7. PubMed ID: 16091681
    [Abstract] [Full Text] [Related]

  • 37. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence.
    Parente F, Bargiggia S, Bollani S, Colombo E, Bianchi Porro G.
    Hepatogastroenterology; 1998 Mar 12; 45(22):990-3. PubMed ID: 9755995
    [Abstract] [Full Text] [Related]

  • 38. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Mar 12; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Zinc compounds as therapeutic agents in peptic ulcer.
    Baños JE, Bulbena O.
    Methods Find Exp Clin Pharmacol; 1989 Mar 12; 11 Suppl 1():117-22. PubMed ID: 2657281
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.